January 2018 Review Show with Nathan and Laura: CRISPR vs The Immune System, Biotech Math, and MinION's Big Test

Mendelspod Podcast

Content provided by Mendelspod Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mendelspod Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

6y ago

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on August 28, 2022 01:25 (1+ y ago). Last successful fetch was on July 07, 2022 17:30 (2y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Some stocks are up on news of big biotech mergers, but others are down on hearing of the latest difficulties of gene therapy. One thing’s for sure—blood diseases are where it’s at. Speaking of the latest difficulties, we start our January review by going back to that paper out of Stanford about a new obstacle to using CRISPR as a new drug platform. It’s called the human immune system. Major roadblock or small warning light?

396 episodes

#Science #Genetic Testing #Natural Sciences